Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 5 de 5
1.
J Neurosci ; 44(19)2024 May 08.
Article En | MEDLINE | ID: mdl-38553047

Glycinergic neurons regulate nociceptive and pruriceptive signaling in the spinal cord, but the identity and role of the glycine-regulated neurons are not fully known. Herein, we have characterized spinal glycine receptor alpha 3 (Glra3) subunit-expressing neurons in Glra3-Cre female and male mice. Glra3-Cre(+) neurons express Glra3, are located mainly in laminae III-VI, and respond to glycine. Chemogenetic activation of spinal Glra3-Cre(+) neurons induced biting/licking, stomping, and guarding behaviors, indicative of both a nociceptive and pruriceptive role for this population. Chemogenetic inhibition did not affect mechanical or thermal responses but reduced behaviors evoked by compound 48/80 and chloroquine, revealing a pruriceptive role for these neurons. Spinal cells activated by compound 48/80 or chloroquine express Glra3, further supporting the phenotype. Retrograde tracing revealed that spinal Glra3-Cre(+) neurons receive input from afferents associated with pain and itch, and dorsal root stimulation validated the monosynaptic input. In conclusion, these results show that spinal Glra3(+) neurons contribute to acute communication of compound 48/80- and chloroquine-induced itch in hairy skin.


Pruritus , Receptors, Glycine , Spinal Cord , Animals , Pruritus/chemically induced , Pruritus/metabolism , Mice , Receptors, Glycine/metabolism , Male , Female , Spinal Cord/metabolism , Spinal Cord/drug effects , Chloroquine/pharmacology , Mice, Transgenic , Skin/innervation , Mice, Inbred C57BL , p-Methoxy-N-methylphenethylamine/pharmacology , Neurons/metabolism , Neurons/drug effects , Neurons/physiology
2.
BMC Neurosci ; 24(1): 32, 2023 06 01.
Article En | MEDLINE | ID: mdl-37264306

BACKGROUND: The glycinergic system plays an important inhibitory role in the mouse central nervous system, where glycine controls the excitability of spinal itch- and pain-mediating neurons. Impairments of the glycine receptors can cause motor and sensory deficits. Glycine exerts inhibition through interaction with ligand-gated ion channels composed of alpha and beta subunits. We have investigated the mRNA expression of the glycine receptor alpha 3 (Glra3) subunit in the nervous system as well as in several peripheral organs of female and male mice. RESULTS: Single-cell RNA sequencing (scRNA-seq) data analysis on the Zeisel et al. (2018) dataset indicated widespread but low expression of Glra3 in vesicular glutamate transporter 2 (Vglut2, Slc17a6) positive and vesicular inhibitory amino acid transporter (Viaat, Slc32a1)positive neurons of the mouse central nervous system. Highest occurrence of Glra3 expression was identified in the cortex, amygdala, and striatal regions, as well as in the hypothalamus, brainstem and spinal cord. Bulk quantitative real-time-PCR (qRT-PCR) analysis demonstrated Glra3 expression in cortex, amygdala, striatum, hypothalamus, thalamus, pituitary gland, hippocampus, cerebellum, brainstem, and spinal cord. Additionally, male mice expressed higher levels of Glra3 in all investigated brain areas compared with female mice. Lastly, RNAscope spatially validated Glra3 expression in the areas indicated by the single-cell and bulk analyses. Moreover, RNAscope analysis confirmed co-localization of Glra3 with Slc17a6 or Slc32a1 in the central nervous system areas suggested from the single-cell data. CONCLUSIONS: Glra3 expression is low but widespread in the mouse central nervous system. Clear sex-dependent differences have been identified, indicating higher levels of Glra3 in several telencephalic and diencephalic areas, as well as in cerebellum and brainstem, in male mice compared with female mice.


Glycine , Receptors, Glycine , Mice , Male , Female , Animals , Receptors, Glycine/metabolism , Glycine/metabolism , Neurons/metabolism , Brain/metabolism , Spinal Cord/metabolism , RNA, Messenger
3.
Sci Rep ; 11(1): 3239, 2021 02 05.
Article En | MEDLINE | ID: mdl-33547358

Rodent primary somatosensory cortex (S1) is organized in defined layers, where layer IV serves as the main target for thalamocortical projections. Serotoninergic signaling is important for the organization of thalamocortical projections and consequently proper barrel field development in rodents, and the vesicular monoamine transporter 2 (VMAT2) can be detected locally in layer IV S1 cortical neurons in mice as old as P10, but the identity of the Vmat2-expressing neurons is unknown. We here show that Vmat2 mRNA and also Vmat2-Cre recombinase are still expressed in adult mice in a sub-population of the S1 cortical neurons in the barrel field. The Vmat2-Cre cells showed a homogenous intrinsically bursting firing pattern determined by whole-cell patch-clamp, localized radial densely spinous basal dendritic trees and almost exclusively lack of apical dendrite, indicative of layer IV spiny stellate cells. Single cell mRNA sequencing analysis showed that S1 cortical Vmat2-Cre;tdTomato cells express the layer IV marker Rorb and mainly cluster with layer IV neurons, and RNAscope analysis revealed that adult Vmat2-Cre neurons express Vmat2 and vesicular glutamate transporter 1 (Vglut1) and Vglut2 mRNA to a high extent. In conclusion, our analysis shows that cortical Vmat2 expression is mainly confined to layer IV neurons with morphological, electrophysiological and transcriptional characteristics indicative of spiny stellate cells.


Neurons/cytology , Somatosensory Cortex/cytology , Vesicular Monoamine Transport Proteins/genetics , Animals , Female , Gene Expression , Integrases/genetics , Male , Mice , Nerve Net/cytology , Nerve Net/metabolism , Neurons/metabolism , RNA, Messenger/genetics , Somatosensory Cortex/metabolism
4.
J Pharmacol Exp Ther ; 372(1): 73-82, 2020 01.
Article En | MEDLINE | ID: mdl-31771994

Itch stimuli are detected by specialized primary afferents that convey the signal to the spinal cord, but how itch transmission is regulated is still not completely known. Here, we investigated the roles of the neuropeptide Y (NPY)/Y2 receptor system on scratch behavior. The inhibitory Y2 receptor is expressed on mouse primary afferents, and intrathecal administration of the Y2 agonist peptide YY (PYY)3-36 reduced scratch episode frequency and duration induced by compound 48/80, an effect that could be reversed by intrathecal preadministration of the Y2 antagonist BIIE0246. Also, scratch episode duration induced by histamine could be reduced by PYY3-36 In contrast, scratch behavior induced by α-methyl-5HT, protease-activated receptor-2-activating peptide SLIGRL, chloroquine, topical dust mite extract, or mechanical itch induced by von Frey filaments was unaffected by stimulation of Y2 Primary afferent neurons expressing the Npy2r gene were found to coexpress itch-associated markers such as natriuretic peptide precursor b, oncostatin M receptor, and interleukin (IL) 31 receptor A. Accordingly, intrathecal PYY3-36 reduced the scratch behavior induced by IL-31. Our findings imply that the NPY/Y2 system reduces histaminergic and IL-31-associated itch through presynaptic inhibition of a subpopulation of itch-associated primary afferents. SIGNIFICANCE STATEMENT: The spinal neuropeptide Y system dampens scratching behavior induced by histaminergic compounds and interleukin 31, a cytokine involved in atopic dermatitis, through interactions with the Y2 receptor. The Y2 receptor is expressed by primary afferent neurons that are rich in itch-associated neurotransmitters and receptors such as somatostatin, natriuretic peptide precursor b, and interleukin 31 receptors.


Antipruritics/pharmacology , Dermatitis, Atopic/metabolism , Neurons, Afferent/metabolism , Peptide Fragments/pharmacology , Peptide YY/pharmacology , Pruritus/metabolism , Receptors, Neuropeptide Y/metabolism , Animals , Antipruritics/administration & dosage , Antipruritics/therapeutic use , Arginine/analogs & derivatives , Arginine/toxicity , Benzazepines/toxicity , Cells, Cultured , Chloroquine/pharmacology , Dermatitis, Atopic/drug therapy , Ganglia, Spinal/cytology , Histamine/pharmacology , Histamine/toxicity , Interleukins/pharmacology , Interleukins/toxicity , Male , Mice , Mice, Inbred C57BL , Natriuretic Peptide, Brain/genetics , Natriuretic Peptide, Brain/metabolism , Neurons, Afferent/drug effects , Neurons, Afferent/physiology , Oligopeptides/pharmacology , Peptide Fragments/administration & dosage , Peptide Fragments/therapeutic use , Peptide YY/administration & dosage , Peptide YY/therapeutic use , Pruritus/drug therapy , Pruritus/etiology , Receptors, Neuropeptide Y/genetics , Receptors, Oncostatin M/genetics , Receptors, Oncostatin M/metabolism , Serotonin/pharmacology
5.
Sci Rep ; 9(1): 16573, 2019 11 12.
Article En | MEDLINE | ID: mdl-31719558

Dorsal horn gastrin-releasing peptide receptor (GRPR) neurons have a central role in itch transmission. Itch signaling has been suggested to be controlled by an inhibitory network in the spinal dorsal horn, as increased scratching behavior can be induced by pharmacological disinhibition or ablation of inhibitory interneurons, but the direct influence of the inhibitory tone on the GRPR neurons in the itch pathway have not been explored. Here we have investigated spinal GRPR neurons through in vitro and bioinformatical analysis. Electrophysiological recordings revealed that GRPR neurons receive local spontaneous excitatory inputs transmitted by glutamate and inhibitory inputs by glycine and GABA, which were transmitted either by separate glycinergic and GABAergic synapses or by glycine and GABA co-releasing synapses. Additionally, all GRPR neurons received both glycine- and GABA-induced tonic currents. The findings show a complex inhibitory network, composed of synaptic and tonic currents that gates the excitability of GRPR neurons, which provides direct evidence for the existence of an inhibitory tone controlling spontaneous discharge in an itch-related neuronal network in the spinal cord. Finally, calcium imaging revealed increased levels of neuronal activity in Grpr-Cre neurons upon application of somatostatin, which provides direct in vitro evidence for disinhibition of these dorsal horn interneurons.


Interneurons/metabolism , Neural Inhibition/physiology , Receptors, Bombesin/metabolism , Spinal Cord/metabolism , Action Potentials/drug effects , Animals , Female , Glycine/metabolism , Integrases/metabolism , Interneurons/drug effects , Male , Mice, Inbred C57BL , Posterior Horn Cells/drug effects , Posterior Horn Cells/metabolism , Protein Subunits/metabolism , Signal Transduction/drug effects , Somatostatin/pharmacology , Synapses/drug effects , Synapses/metabolism , gamma-Aminobutyric Acid/metabolism
...